On September 8, 2020 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported that it will participate in the following virtual investor conferences in September (Press release, Akebia, SEP 8, 2020, View Source [SID1234564759]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Conference
John P. Butler, President and Chief Executive Officer, to participate in virtual one-on-one meetings on Wednesday, September 9.

H.C. Wainwright 22nd Annual Global Investment Conference
Michel Dahan, Chief Operating Officer, and David Spellman, Chief Financial Officer, to participate in a virtual fireside chat on Monday, September 14, at 10:00 a.m. ET.

Morgan Stanley Virtual 18th Annual Global Healthcare Conference
John P. Butler, President and Chief Executive Officer, to participate in a fireside chat on Tuesday, September 15, at 1:15 p.m. ET.

Cantor Virtual Global Healthcare Conference
John P. Butler, President and Chief Executive Officer, to present on Wednesday, September 16, at 1:20 p.m. ET.
Where applicable, live webcasts of Akebia’s presentations will be made available on the Investors section on the Company’s website at View Source